These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Autologous peripheral stem cell transplantation in systemic sclerosis: An important step forward, but we must temper our enthusiasm!]. Mouthon L Rev Med Interne; 2024 Feb; 45(2):100-103. PubMed ID: 38238136 [TBL] [Abstract][Full Text] [Related]
8. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan. Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554 [TBL] [Abstract][Full Text] [Related]
10. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol. Spierings J; van Rhenen A; Welsing PM; Marijnissen AC; De Langhe E; Del Papa N; Dierickx D; Gheorghe KR; Henes J; Hesselstrand R; Kerre T; Ljungman P; van de Loosdrecht AA; Marijt EW; Mayer M; Schmalzing M; Schroers R; Smith V; Voll RE; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Walker UA; Wuttge DM; van Laar JM BMJ Open; 2021 Mar; 11(3):e044483. PubMed ID: 33737437 [TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011 [TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study. Farge D; Marolleau JP; Zohar S; Marjanovic Z; Cabane J; Mounier N; Hachulla E; Philippe P; Sibilia J; Rabian C; Chevret S; Gluckman E; Br J Haematol; 2002 Dec; 119(3):726-39. PubMed ID: 12437652 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature. Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME; Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550 [TBL] [Abstract][Full Text] [Related]
14. Autologous HSCT in systemic sclerosis: a step forward. Farge D; Gluckman E Lancet; 2011 Aug; 378(9790):460-2. PubMed ID: 21777973 [No Abstract] [Full Text] [Related]
15. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status. Burt RK; Milanetti F Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226 [TBL] [Abstract][Full Text] [Related]